| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |